This information collection request
supports agency guidance regarding "Dear Healthcare Provider"
Letters. Respondents to the collection are manufacturers and
distributors of drugs for which such a letter is required under 21
CFR part 200.5. The burden reflects the estimated time associated
with the coordination and preparation of these letters with
respondents so that they may be issued accordingly. The letters
communicate new and important information about prescription drug
and biological products (drugs).